Related Experiment Video
Updated: May 12, 2026

ROS Live Cell Imaging During Neuronal Development
Published on: February 9, 2021
NOX, NOX Who is There? The Contribution of NADPH Oxidase One to Beta Cell Dysfunction
1Department of Internal Medicine, Strelitz Diabetes Center, Eastern Virginia Medical School Norfolk, VA, USA ; Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School Norfolk, VA, USA.
Abstract:
Predictions of diabetes prevalence over the next decades warrant the aggressive discovery of new approaches to stop or reverse loss of functional beta cell mass. Beta cells are recognized to have a relatively high sensitivity to reactive oxygen species (ROS) and become dysfunctional under oxidative stress conditions. New discoveries have identified NADPH oxidases in beta cells as contributors to elevated cellular ROS. Reviewed are recent reports that evidence a role for NADPH oxidase-1 (NOX-1) in beta cell dysfunction. NOX-1 is stimulated by inflammatory cytokines that are elevated in diabetes. First, regulation of cytokine-stimulated NOX-1 expression has been linked to inflammatory lipid mediators derived from 12-lipoxygenase activity. For the first time in beta cells these data integrate distinct pathways associated with beta cell dysfunction. Second, regulation of NOX-1 in beta cells involves feed-forward control linked to elevated ROS and Src-kinase activation. This potentially results in unbridled ROS generation and identifies candidate targets for pharmacologic intervention. Third, consideration is provided of new, first-in-class, selective inhibitors of NOX-1. These compounds could have an important role in assessing a disruption of NOX-1/ROS signaling as a new approach to preserve and protect beta cell mass in diabetes.
Insights
Reactive oxygen species (ROS) contribute to diabetes by damaging beta cells. Targeting NADPH oxidase-1 (NOX-1) and its signaling pathways offers a new strategy to protect beta cell mass.
Area of Science:
- Endocrinology
- Molecular Biology
- Oxidative Stress Research
Background:
- Diabetes prevalence necessitates novel strategies to preserve pancreatic beta cell mass.
- Beta cells are vulnerable to oxidative stress, leading to dysfunction.
- NADPH oxidases (NOX) are identified as key contributors to elevated reactive oxygen species (ROS) in beta cells.
Purpose of the Study:
- To review recent findings on the role of NADPH oxidase-1 (NOX-1) in beta cell dysfunction.
- To integrate pathways regulating NOX-1 in the context of diabetes-associated inflammation.
- To identify NOX-1 as a potential therapeutic target for preserving beta cell function.
Main Methods:
- Literature review of recent reports on NOX-1 and beta cell dysfunction.
- Analysis of cytokine-stimulated NOX-1 expression regulation by inflammatory lipid mediators.
- Examination of NOX-1 regulation via ROS and Src-kinase activation in beta cells.
Main Results:
- Cytokine-stimulated NOX-1 expression is linked to 12-lipoxygenase-derived lipid mediators, integrating distinct dysfunction pathways.
- NOX-1 regulation involves feed-forward control with ROS and Src-kinase, potentially causing excessive ROS generation.
- Selective NOX-1 inhibitors are emerging as potential therapeutic agents.
Conclusions:
- NOX-1 plays a significant role in diabetes-related beta cell dysfunction.
- The NOX-1/ROS signaling pathway presents a novel target for pharmacologic intervention.
- Disrupting NOX-1 signaling may offer a new approach to protect beta cell mass in diabetes.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Redox Reactions
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology
Oxidation and Reduction of Organic Molecules
The removal of an electron from a molecule, results in a...
Peroxisomes

